Fellowship · Richmond, VA
Sponsored by Virginia Commonwealth University Health System
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
Science (New York, N.Y.) · 2022 · 382 citations · Kyle Hitscherich
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 269 citations · Martin Fleming
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 113 citations · Martin Fleming
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 279 citations · Harry Bear
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.
Frontiers in oncology · 2021 · 206 citations · Jose Trevino
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.
Nature medicine · 2025 · 53 citations · Kyle Hitscherich
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
Gastroenterology · 2026 · 18 citations · Jose Trevino
Diversity, Equity and Inclusion in Medicine: Why It Matters and How do We Achieve It?
Journal of surgical education · 2021 · 105 citations · Tania Arora